Home » Newsletters » BioWorld MedTech

BioWorld MedTech

Aug. 5, 2013

View Archived Issues

Chinese regulations could prove to be a boon to exporters

New regulations introduced in July in China, could raise costs for domestic device manufacturers but may prove to be a boon for importers. Read More

Mitek Sports launches new Healix Knotless Anchor

NewCo on the Go: Optimum TAV achieves pre-clinical milestone

Washington roundup: GAO decries self-referral for IMRT; docs say 'misleading'

New Ventures: Harvard Bioscience to separate from its HART subsidiary

Product News:

Washington roundup II: Cardiologists surprised CMS ready to dump INTERMACS

People in the News:

Financings roundup: Truven Health closeson $372M senior note exchange offer

Deals roundup: ICU Medical rumored to be in talks to sell itself to GTCR

Keeping you up to date on recent developments in neurology

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 20, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...